A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

被引：8

作者：

Zhang, Xiaomei ^{[1
]}

Lv, Hairong ^{[2
]}

Xiao, Xia ^{[2
]}

Bai, Xue ^{[2
]}

Liu, Pengjiang ^{[2
]}

Pu, Yedi ^{[2
]}

Meng, Juanxia ^{[2
]}

Zhu, Haibo ^{[2
]}

Wang, Zhao ^{[2
]}

Zhang, Huan ^{[2
]}

Zhang, Yu ^{[2
]}

Lv, Cuicui ^{[2
]}

Ma, Li ^{[2
]}

Yuan, Ting ^{[2
]}

Zhang, Meng ^{[2
]}

Sun, Rui ^{[1
]}

Zhao, Yifan ^{[2
]}

Cao, Xinping ^{[2
]}

Guo, Ruiting ^{[2
]}

Zhang, Yi ^{[2
]}

Guo, Shujing ^{[2
]}

Liu, Jile ^{[2
]}

Zhao, Mingfeng ^{[1
,2
]}

机构：

[1] Nankai Univ, Med Sch, Tianjin, Peoples R China

[2] Tianjin First Cent Hosp, Tianjin, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180387

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial
Kater, Arnon P.
Christensen, Jacob Haaber
Bentzen, Hans Herluf
Niemann, Carsten Utoft
Hutchings, Martin
Chen, Jenny
Rios, Marcia
Palenski, Tammy
Li, Tommy
Mato, Anthony R.
BLOOD, 2021, 138
[42] A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
Wartman, Lukas D.
Fiala, Mark A.
Hawkins, Emily
Fletcher, Theresa
Allen, Melissa
Cashen, Amanda F.
DiPersio, John F.
Jacoby, Meagan
Stockerl-Goldstein, Keith E.
Pusic, Iskra
Uy, Geoffrey L.
Westervelt, Peter
Vij, Ravi
BLOOD, 2014, 124 (21)
[43] A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
Wartman, Lukas D.
Fiala, Mark A.
Fletcher, Theresa
Hawkins, Emily R.
Cashen, Amanda
DiPersio, John F.
Jacoby, Meagan A.
Stockerl-Goldstein, Keith E.
Pusic, Iskra
Uy, Geoffrey L.
Westervelt, Peter
Vij, Ravi
LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 728 - 730
[44] A Phase 1 Clinical Trial of Selinexor in Combination with Decitabine in Patients with Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
Bhatnagar, Bhavana
Klisovic, Rebecca B.
Walker, Alison R.
Vasu, Sumithra
Mims, Alice S.
Walsh, Katherine J.
Behbehani, Gregory K.
Blachly, James S.
Vittorio, Molly
Zhao, Qiuhong
Ruppert, Amy S.
Orwick, Shelley
Ranganathan, Parvathi
Byrd, John C.
Blum, William
Garzon, Ramiro
BLOOD, 2016, 128 (22)
[45] Richter's Transformation after CD-19 Directed CAR-T Cells for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Blackmon, Amanda
Danilov, Alexey V.
Wang, Lili
Pillai, Raju
Mirshkarlo, Hormoz Babaei
Rosen, Steven T.
Siddiqi, Tanya
BLOOD, 2021, 138
[46] Safety and Efficacy of CD19 CAR-T Cells for Refractory Systemic Sclerosis: A Phase I Clinical Trial
Feng, Jingjing
Hu, Yongxian
Zhang, Mingming
Cao, Heng
Ke, Yini
Xu, Huijun
Cui, Jiazhen
Zhang, Yanlei
Chang, Alex Hongsheng
Lin, Jin
Wei, Guoqing
Huang, He
BLOOD, 2022, 140 : 10335 - 10336
[47] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Griffiths, Elizabeth A.
Brady, William
Tan, Wei
Vigil, Carlos E.
Thompson, James E.
Ford, Laurie A.
Dickey, Noelle M.
Sperrazza, Jill
Wang, Eunice S.
Wetzler, Meir
BLOOD, 2014, 124 (21)
[48] Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia
Bieker, R
Lerchenmüller, C
Wehmeyer, J
Serve, HL
Mesters, RM
Büchner, T
Berdel, WE
ONCOLOGY REPORTS, 2003, 10 (04) : 915 - 920
[49] Phase I clinical trial of CD19CAR-T cells secreting PD-1-targeting IL-21 in advanced relapsed/refractory acute lymphoblastic leukemia
Jing, Yu
Li, Ying
Dou, Liping
Zhang, Shengjuan
Tian, Ran
Wang, Guojing
Cheng, Xiangrui
Zhao, Jitao
Li, Hang
An, Yueyi
Yang, Naibo
Wang, Shengdian
CANCER RESEARCH, 2024, 84 (07)
[50] Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia
Zhang, Rui
Zhao, Yifan
Chai, Xiao
Wang, Yingshuai
Zhao, Mohan
Guo, Shujing
Zhang, Yu
Zhao, Mingfeng
TRANSLATIONAL ONCOLOGY, 2025, 52

← 1 2 3 4 5 →